XIAP overexpressing inflammatory breast cancer patients have high infiltration of immunosuppressive subsets and increased TNFR1 signaling targetable with Birinapant

Bron
Translational oncology - ISSN 1936-5233-43 (2024) p. 1-13
Auteur(s)

Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors

Bron
Oncoimmunology - ISSN 2162-402X-10:1 (2021) p.
Auteur(s)